1164106-06-2

Basic information

• Product Name: benzyl 4-((2-oxooxazolidin-5-yl)methyl)piperazine-1-carboxylate
• Synonyms: benzyl 4-((2-oxooxazolidin-5-yl)methyl)piperazine-1-carboxylate
• CAS NO: 1164106-06-2
• Molecular Weight: 319.36
• Mol File: 1164106-06-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: benzyl 4-((2-oxooxazolidin-5-yl)methyl)piperazine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl 4-((2-oxooxazolidin-5-yl)methyl)piperazine-1-carboxylate(1164106-06-2)
• EPA Substance Registry System: benzyl 4-((2-oxooxazolidin-5-yl)methyl)piperazine-1-carboxylate(1164106-06-2)

Safety Data

• Hazardous Substances Data: 1164106-06-2(Hazardous Substances Data)

Upstream product

• 22625-57-6 5-(chloromethyl)-1,3-oxazolidin-2-one 
• 31166-44-6 phenylmethyl 1-piperazinecarboxylate 

Downstream Products

• 1164105-54-7 benzyl 4-((3-(5-(5-(cyclopropylcarbamoyl)-2-methylphenyl)pyridin-2-yl)-2-oxooxazolidin-5-yl)methyl)piperazine-1-carboxylate 

Relevant articles and documents

LINEAR TRICYCLIC COMPOUNDS AS P38 KINASE INHIBITORS

The present invention comprises a new class of compounds useful for the prophylaxis and treatment of p38 kinase mediated diseases, including inflammation and related conditions. The compounds have a general Formula I wherein A, B1, B2, C1-4, L1, R1, R2, R5, m and n are defined herein. The invention also comprises pharmaceutical compositions including one or more compounds of Formula I, methods of use such as treatment of kinase mediated diseases by administering the compounds of Formula I or compositions including the compounds of Formula I, and intermediates and processes useful for the preparation of compounds of Formula I.